Cannabis-Induced Mania Following COVID-19 Self-Medication: A Wake-Up Call to Improve Community Awareness

References

• Arlington APA. Diagnostic and Statistical Manual of Mental Disorders. J Am Psychiatric Assoc. 2013:21.
   Google Scholar
• Sideli L, Quigley H, La Cascia C, Murray R. Cannabis use and the risk for psychosis and affective disorders. J Dual Diagnosis. 2020;16(1):22–42. doi:10.1080/15504263.2019.1674991
   PubMed Web of Science ®Google Scholar
• Rong C, Lee Y, Carmona NE, et al. Cannabidiol in medical marijuana: research vistas and potential opportunities. Pharmacol Res. 2017;121:213–218. doi:10.1016/j.phrs.2017.05.005
   PubMed Web of Science ®Google Scholar
• O’Sullivan SE, Stevenson CW, Laviolette SRJC, Research C. Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders? Cannabis Cannabinoid Res. 2020.
   Google Scholar
• Costiniuk CT, Jenabian M-AJC, Reviews GF. Acute inflammation and pathogenesis of SARS-CoV-2 infection: cannabidiol as a potential anti-inflammatory treatment? Growth Factor Rev. 2020;53:63–65. doi:10.1016/j.cytogfr.2020.05.008
   PubMed Web of Science ®Google Scholar
• Esposito G, Pesce M, Seguella L, et al. The potential of cannabidiol in the COVID‐19 pandemic: a hypothesis letter. Br J Pharmacol. 2020;177(21):4967.
   PubMed Web of Science ®Google Scholar
• Onaivi ES, Sharma V. Cannabis for COVID-19: can cannabinoids quell the cytokine storm? Future Sci. 2020;6(8):FSO625. doi:10.2144/fsoa-2020-0124
   PubMed Web of Science ®Google Scholar
• Rossi F, Tortora C, Argenziano M, Di Paola A, Punzo F. Cannabinoid Receptor Type 2: a Possible Target in SARS-CoV-2 (CoV-19) Infection? Int J Mol Sci. 2020;21(11):3809.
   PubMed Web of Science ®Google Scholar
• Xiong J, Lipsitz O, Nasri F, et al. Impact of COVID-19 pandemic on mental health in the general population: a systematic review. J Affect dis. 2020;277:55-64.
   Web of Science ®Google Scholar
• Molento MB. COVID-19 and the rush for self-medication and self-dosing with ivermectin: a word of caution. One Health. 2020. 10:100148.
   Google Scholar
• Jouanjus E, Lapeyre‐Mestre M, Micallef J, Abuse F. Cannabis use: signal of increasing risk of serious cardiovascular disorders. J Am Heart Assoc. 2014;3(2):e000638. doi:10.1161/JAHA.113.000638
   PubMed Web of Science ®Google Scholar
• Karila L, Roux P, Rolland B, et al. Acute and long-term effects of cannabis use: a review. Curr Pharm Design. 2014;20(25):4112–4118. doi:10.2174/13816128113199990620
   PubMed Web of Science ®Google Scholar
• Coscas S, Benyamina A, Reynaud M, Karila L. Psychiatric complications of cannabis use. La Revue du praticien. 2013;63(10):1426–1428.
   PubMedGoogle Scholar
• Worldometer. Coronavirus Death Toll and Trends – worldometer; 2021. Available from: https://www.worldometers.info/coronavirus/coronavirus-death-toll/. Accessed January 1, 2021.
   Google Scholar
• Thota SM, Balan V, Sivaramakrishnan VJPR. Natural products as home-based prophylactic and symptom management agents in the setting of COVID. Phytotherapy Res. 2020;34(12):3148–3167. doi:10.1002/ptr.6794
   Web of Science ®Google Scholar
• Ministry of Health Uganda; The Department of Health Promotion EHC. Basic information for covid-19 patients undergoing home based isolation and care; 2020. Available from: https://www.health.go.ug/cause/basic-information-for-covid-19-patients-undergoing-home-based-isolation-and-care/. Accessed February 24, 2021.
   Google Scholar
• Hao F, Tan W, Jiang L, et al. Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? Brain. 2020;87:100–106.
   Web of Science ®Google Scholar
• Suchithra B, As NU. Study on Awareness about Self-Medications and it’s Complications Among Homemakers. J Health Allied Sci. 2017;7(01):061–065.
   Google Scholar
• Rowland TA, Marwaha S. Epidemiology and risk factors for bipolar disorder. Therapeutic Adv Psychopharmacol. 2018;8(9):251–269. doi:10.1177/2045125318769235
   PubMed Web of Science ®Google Scholar
• Kroon JS, Wohlfarth TD, Dieleman J, et al. Incidence rates and risk factors of bipolar disorder in the general population: a population‐based cohort study. Bipolar Disorders. 2013;15(3):306–313. doi:10.1111/bdi.12058
   Web of Science ®Google Scholar
• Gibbs M, Winsper C, Marwaha S, Gilbert E, Broome M, Singh S. Cannabis use and mania symptoms: a systematic review and meta-analysis. J Affect Dis. 2015;171:39–47. doi:10.1016/j.jad.2014.09.016
   PubMed Web of Science ®Google Scholar
• Bally N, Zullino D, Aubry J-M. Cannabis Use and First Manic Episode. J AffecT Dis. 2014;165:103–108.
   PubMed Web of Science ®Google Scholar
• Steardo Jr L, Steardo L, Verkhratsky A. Psychiatric face of COVID-19. Translat Psychiatry. 2020;10(1):1–12.
   Web of Science ®Google Scholar
• Rong C, Carmona NE, Lee YL, et al. Drug-drug interactions as a result of co-administering Δ9-THC and CBD with other psychotropic agents. Exp Opinion Drug Safety. 2018;17(1):51–54. doi:10.1080/14740338.2017.1397128
   PubMed Web of Science ®Google Scholar
• Choi KR, Heilemann MV, Fauer A, Mead M. A second pandemic: mental health spillover from the novel coronavirus (COVID-19). J Am Psychiatric Nurs Assoc. 2020;26(4)340-343.
   Web of Science ®Google Scholar
• Kondo KK, Morasco BJ, Nugent SM, et al. Pharmacotherapy for the treatment of cannabis use disorder: a systematic review. Ann Int Med. 2020;172(6):398–412. doi:10.7326/M19-1105
   Web of Science ®Google Scholar
• Burgess C, Miller CJ, Franz A, et al. Practical lessons learned for assessing and treating bipolar disorder via telehealth modalities during the COVID‐19 pandemic. Bipolar Disorders. 2020;22(6):556–557. doi:10.1111/bdi.12969
   Web of Science ®Google Scholar
• Ho CS, Chee CY, Ho RC. Mental health strategies to combat the psychological impact of COVID-19 beyond paranoia and panic. Ann Acad Med Singapore. 2020;49(3):155–160.
   Web of Science ®Google Scholar
• Zhang M, Ho RJT. Moodle: The Cost Effective Solution for Internet Cognitive Behavioral Therapy (I-CBT) Interventions. Tech Health Care. 2017;25(1):163–165.
   PubMed Web of Science ®Google Scholar
• Soh HL, Ho RC, Ho CS, Tam WWJSM. Efficacy of digital cognitive behavioural therapy for insomnia: a meta-analysis of randomised controlled trials. Sleep Med. 2020;75:315–325. doi:10.1016/j.sleep.2020.08.020
   PubMed Web of Science ®Google Scholar